A detailed history of Prudential Financial Inc transactions in Axonics, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 3,861 shares of AXNX stock, worth $274,053. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,861
Previous 4,016 3.86%
Holding current value
$274,053
Previous $269,000 0.37%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$67.3 - $69.67 $10,431 - $10,798
-155 Reduced 3.86%
3,861 $268,000
Q2 2024

Aug 13, 2024

BUY
$66.47 - $69.65 $11,499 - $12,049
173 Added 4.5%
4,016 $269,000
Q1 2024

May 14, 2024

SELL
$56.67 - $69.36 $1.83 Million - $2.24 Million
-32,312 Reduced 89.37%
3,843 $265,000
Q4 2023

Feb 13, 2024

BUY
$49.38 - $63.75 $5,431 - $7,012
110 Added 0.31%
36,155 $2.25 Million
Q3 2023

Nov 13, 2023

SELL
$48.64 - $62.51 $32,686 - $42,006
-672 Reduced 1.83%
36,045 $2.02 Million
Q2 2023

Aug 11, 2023

SELL
$47.99 - $60.21 $96,891 - $121,563
-2,019 Reduced 5.21%
36,717 $1.85 Million
Q1 2023

May 12, 2023

SELL
$52.6 - $67.34 $459,092 - $587,743
-8,728 Reduced 18.39%
38,736 $2.11 Million
Q4 2022

Feb 14, 2023

SELL
$59.56 - $76.6 $555,218 - $714,065
-9,322 Reduced 16.42%
47,464 $0
Q3 2022

Nov 04, 2022

BUY
$57.96 - $78.12 $484,893 - $653,551
8,366 Added 17.28%
56,786 $4 Million
Q2 2022

Aug 15, 2022

SELL
$39.5 - $64.42 $1.26 Million - $2.06 Million
-31,965 Reduced 39.76%
48,420 $2.74 Million
Q1 2022

May 13, 2022

BUY
$43.74 - $62.76 $1.58 Million - $2.27 Million
36,163 Added 81.78%
80,385 $5.03 Million
Q4 2021

Feb 14, 2022

BUY
$50.01 - $73.35 $738,147 - $1.08 Million
14,760 Added 50.1%
44,222 $2.63 Million
Q3 2021

Nov 15, 2021

BUY
$59.21 - $78.66 $38,604 - $51,286
652 Added 2.26%
29,462 $1.95 Million
Q2 2021

Aug 16, 2021

BUY
$51.39 - $66.9 $1.48 Million - $1.93 Million
28,810 New
28,810 $1.83 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.